VNS Therapy epilepsy seizure devices, Aspire HC and Aspire SR, are FDA approved for MRI scans.- LivaNova

LivaNova PLC announced that its latest VNS Therapy systems (�VNS Therapy�) received FDA approval for expanded MRI labeling, affirming VNS Therapy as the only epilepsy device approved by the FDA for MRI scans. This FDA approval ensures VNS Therapy patients with the latest technology may visit any MRI center in the U.S. and have access to more than 90 percent of scans routinely performed on patients with epilepsy.

Currently, Aspire HC and Aspire SR models of VNS Therapy technology provide for this expanded MRI access, enabling patients to obtain high-quality MRI scans and optimize treatment. Additional benefits include:� improving ease of use and access to care � eliminating the need for special MRI equipment.� providing comprehensive treatment throughout a patient�s lifetime.

To date, VNS Therapy�a minimally invasive treatment designed to prevent seizures before they start and stop them if they do�has been used by more than 100,000 patients worldwide. More than one in three people with epilepsy has drug-resistant seizures, meaning seizures persist in spite of treatment with antiepileptic medications. It is estimated that approximately one million people suffer from drug-resistant epilepsy in the U.S. alone.